Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 3 boards, counting each seat separately. Longest: Moderna Inc., 3 years.
Moderna Inc.
Director
Foghorn Therapeutics Inc.
Director
Generate Biomedicines Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 21, 2026 | Moderna Inc. | Option exercise | +9,263 | $19.15 | $177,386 |
| May 21, 2026 | Moderna Inc. | Open-market sale | −9,263 | $46.84 | $433,879 |
| Mar 2, 2026 | Generate Biomedicines Inc. | Derivative conversion | +12,723,940 | — | — |
| Mar 2, 2026 | Generate Biomedicines Inc. | Derivative conversion | +12,723,940 | — | — |
| Mar 2, 2026 | Generate Biomedicines Inc. | Derivative conversion | +13,702,224 | — | — |
| Mar 2, 2026 | Generate Biomedicines Inc. | Derivative conversion | +13,702,224 | — | — |
| Mar 2, 2026 | Generate Biomedicines Inc. | Derivative conversion | +987,491 | — | — |
| Mar 2, 2026 | Generate Biomedicines Inc. | Derivative conversion | +987,491 | — | — |
| Mar 2, 2026 | Generate Biomedicines Inc. | Derivative conversion | +2,777,752 | — | — |
| Mar 2, 2026 | Generate Biomedicines Inc. | Derivative conversion | +2,777,752 | — | — |
| Mar 2, 2026 | Generate Biomedicines Inc. | Derivative conversion | +2,777,752 | — | — |
| Mar 2, 2026 | Generate Biomedicines Inc. | Derivative conversion | +2,777,752 | — | — |
| Mar 2, 2026 | Generate Biomedicines Inc. | Open-market purchase | +1,562,500 | $16.00 | $25,000,000 |
| Mar 2, 2026 | Generate Biomedicines Inc. | Open-market purchase | +1,562,500 | $16.00 | $25,000,000 |
| Mar 2, 2026 | Generate Biomedicines Inc. | Open-market purchase | +1,562,500 | $16.00 | $25,000,000 |
Questions about Noubar Afeyan
What boards is Noubar Afeyan on?
Noubar Afeyan sits on the boards of Foghorn Therapeutics Inc., Generate Biomedicines Inc. and Moderna Inc.
How long has Noubar Afeyan served on boards?
Our records show at least 5 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.